早期子宫平滑肌肉瘤保留卵巢趋势及与生存的关联
该研究基于美国国家癌症数据库(NCDB)2010–2016年数据,纳入50岁以下I期子宫平滑肌肉瘤(LMS)行子宫切除术的患者。结果显示保留卵巢(OCN)比例从41.2%降至14.3%,且低分化肿瘤患者更少行OCN(aRR 0.59)。倾向评分加权后,OCN与全因死亡率无关(HR 1.19)。
要点
- I期LMS年轻患者保留卵巢比例从2010年41.2%降至2016年14.3%。
- 低分化肿瘤患者保留卵巢的可能性显著低于高分化(aRR 0.59)。
- 倾向评分加权后,保留卵巢与死亡率无关(HR 1.19)。
核心结论
- 在50岁以下I期子宫平滑肌肉瘤患者中,保留卵巢比例逐年下降,但保留卵巢与全因死亡率无显著关联。
研究设计与样本
- 基于美国国家癌症数据库(NCDB)的回顾性队列研究,纳入2010–2016年50岁以下I期LMS行子宫切除术患者,共225例(28%)行保留卵巢。
主要发现
- 保留卵巢率从2010年41.2%降至2016年14.3%,各年龄亚组趋势一致。
- 低分化肿瘤患者保留卵巢可能性低于高分化肿瘤(aRR 0.59;95% CI 0.40–0.86)。
- 倾向评分加权后,保留卵巢与全因死亡率无关联(HR 1.19,95% CI 0.80–1.77)。
- 保留卵巢组5年生存率为67.1%(95% CI 59.8–75.2%),卵巢切除组为72.2%(95% CI 67.2–77.5%)。
临床怎么用
- 对于I期子宫平滑肌肉瘤的绝经前女性,可考虑保留卵巢以获取健康益处。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore trends of ovarian conservation (OCN) over time in young women with early stage leiomyosarcoma (LMS) and examine the association between OCN and survival. METHODS: Patients under the age of 50 who were diagnosed with stage I LMS who underwent hysterectomy with and without oophorectomy between 2010 and 2016 were identified in the National Cancer Database (NCDB). Performance of oophorectomy vs. OCN was determined using surgery codes. Trends of OCN were reported. Multivariable regression models were fit to estimate predictors of OCN. An inverse probability of treatment weighted propensity score method was used to examine the association between all-cause mortality and OCN. RESULTS: Overall, 225 patients (28%) underwent OCN. Rates of OCN decreased from 41.2% (2010) to 14.3% (2016); this finding was consistent across age groups: <35, 35-39, 40-44, and 45-49 years. Race, insurance, and stage did not affect performance of OCN. Women with poorly differentiated tumors were less likely to undergo OCN compared to well-differentiated tumors (aRR 0.59; 95% CI 0.40-0.86). After propensity score weighting, there was no association between OCN and mortality (HR 1.19, 95% CI 0.80-1.77). Five-year survival for the OCN group was 67.1% (95% CI 59.8-75.2%) compared to 72.2% for the oophorectomy group (95% CI 67.2-77.5%). CONCLUSIONS: OCN for early stage LMS in premenopausal women has decreased over time. There was no association between OCN and mortality among women with stage I LMS. OCN should be considered in premenopausal women with stage I LMS given the health benefits.
引用
- Sia TY, Huang Y, Gockley A, et al. Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma. Gynecol Oncol. 2021. PMID: 33810881. doi:10.1016/j.ygyno.2021.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。